GNC / GLC Active Projects

  1. Cost Effectiveness of Screening for High Risk MASLD (United States and United Kingdom)
  2. Economic Burden of MASH (US, Germany, Spain, Brazil, Saudi Arabia, Japan, France, Italy & UK
  3. Consensus Recommendation for MASLD, Including US-Published in Gastroenterology
  4. United States’ APP Focused Recommendations for MASLD-Published in JCG
  5. Global Survey of Providers Regarding NITs for MASLD
  6. MASH Educational Alliance in the United States
  7. MASLD Educational Material for Patients and Providers in the US (Adults and Paediatrics)
  8. Liver Transplant for MASH and other Liver Diseases in United States and Europe
  9. Global Survey of Pregnancy in Viral Hepatitis
  10. Stigma in NAFLD (Additional Analysis)
  11. Stigma in ALD (Patients and Providers Perspective)
  12. Practice patterns in HBV/HDV
  13. Association of food insecurity with MASLD prevalence and liver-related mortality (US)
  14. Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in MASLD
  15. Trends & Disparities in Steatotic Liver Disease (NHANES 2019–2023)-United States
  16. Long-Term Outcomes of MetALD & ALD (NHANES Restricted Data)
  17. Causes of Premature Mortality Across the Spectrum of SLD in USA (NVSS)
  18. Socioeconomic & Environmental Determinants of Preventable MASLD Mortality in the US
  19. Impact of Glycemic Severity on MASLD Progression and Related Complications in the US
  20. Development of educational lifestyle materials for US Patients and Providers
  21. Weekend Warrior Physical Activity Pattern Protects Against MASLD and Mortality Comparable to Regular Weekly Exercise: Findings from a US National Cohort
  22. Premature mortality from SLD in the USA: Interaction of alcohol and MS
  23. Middle East Burden of MASLD & MASH
  24. Addressing Underreporting in Alcohol in MASLD, MetALD and ALD (NHANES and NVSS)
  25. MASLD in Africa Task Force
  26. Liver Transplantation for Hepatitis Delta (US and Europe)
  27. Development and Validation of CLDQ-ALD
  28. Development and validation of Short Food Frequency Questionnaire
  29. PEth testing for MASLD Biobank
  30. The Global MASLD Project (G-MASLD)
    1. Assessment of Liver Biopsy, NIT, Clinical Data and Outcomes
    2. Central reading of scanned biopsies and morphometry Sub-project
    3. Global SNP in MASLD Sub-project
    4. Global Met-ALD Sub-project
    5. Global HCC in MASLD Sub-project
  31. Liver Mortality & Alcohol Consumption in Adolescents (NHANES Restricted) in the US
  32. MASH Liver Transplants: Global Organ Donation & Transplantation Data (2011–2023)
  33. ALD Prevalence and Outcomes meta-analysis project.
  34. Economic Burden of MASLD in T2D patients in the U.S.
  35. Validation of short ultra-processed food (UPF) questionnaire in the United States
  36. Omics of MASLD- Analyzing genomics, proteomics, and other omics data for 400-500 patients from the US
  37. Global Survey to Identify Gaps in Pediatric Liver Disease
  38. Prevalence and Mortality of Delta Virus in the United States using NHANES